Showing all 4 results
Bisoprolol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (distinctively shaped/scored). The low-dose range is critical for the “Start Low, Go Slow” titration required in heart failure.
Active Ingredient Strength (Standard) Shape/Color Primary Role Bisoprolol Fumarate USP/BP 2.5 mg White (Scored) Heart Failure Initiation Bisoprolol Fumarate USP/BP 5 mg Yellow/Pink (Scored) Standard Hypertension Bisoprolol Fumarate USP/BP 10 mg Orange/White High Dose Maintenance Excipients Q.S. Microcrystalline Cellulose / Hypromellose Filler / Coating Carvedilol Tablets
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets. Because therapy for Heart Failure requires very precise “low dose” initiation, we offer the full titration range.
Active Ingredient Strength (Standard) Color Code (Typical) Role Carvedilol USP/BP 3.125 mg White/Pink CHF Initiation (Critical) Carvedilol USP/BP 6.25 mg Yellow Titration Step 1 Carvedilol USP/BP 12.5 mg Tan/Peach Titration Step 2 Carvedilol USP/BP 25 mg White Target Maintenance Dose Enalapril Tablets
FreeProduct Composition & Strength
We supply this product as Uncoated Tablets (scored for titration). The wide range of strengths allows for the “Start Low, Go Slow” dosing strategy essential for heart failure.
Active Ingredient Strength (Standard) Primary Role Enalapril Maleate USP/BP 2.5 mg Heart Failure Initiation Enalapril Maleate USP/BP 5 mg Hypertension Initiation Enalapril Maleate USP/BP 10 mg Maintenance Dose Enalapril Maleate USP/BP 20 mg High Strength Lisinopril Tablet
FreeProduct Composition & Available Portfolio Range
We manufacture Lisinopril in exact, compendial strengths calibrated to support initial introductory titration up to high-potency cardioprotective maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lisinopril Anhydrous / Dihydrate USP / BP / IP 5 mg Oral Solid Uncoated Tablet Initial Titration: For low-dose introductory management, pediatric hypertension, or initial combination therapy initiation. Lisinopril Anhydrous / Dihydrate USP / BP / IP 10 mg Oral Solid Uncoated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Lisinopril Anhydrous / Dihydrate USP / BP / IP 20 mg Oral High-Potency Solid Tablet Advanced Cardioprotection: High-strength configuration calibrated for severe heart failure management and post-infarction survival optimization.
